Full STEAM ahead for Almac Group’s Primary School Science Initiative

January 24, 2023

The Almac Group is giving almost 1,000 P6 and P7 children from 16 primary schools across Northern Ireland access to “Science in a Box”, a fun and engaging curriculum-linked science programme.

This is the second phase of Almac’s £45,000 investment in its STEAM box outreach programme which is on track to reach 50 schools and approximately 3,000 children over the next three years.

This initiative is one part of Almac’s overall mission to inspire the next generation of scientists, engineers, and technologists by helping children to learn vital science, technology, engineering, arts and maths (STEAM) skills, sparking their natural curiosity about the world around them.

Dr Frances Weldon, STEM Outreach Manager for Almac Group said: “We are excited to engage with even more schools and pupils this year with this initiative.  It delivers fun, interactive Biology-based programmes to P6 / P7 classes and supports teachers in the delivery of the World Around Us curriculum.   Over the course of five lessons, the children will learn about the building blocks of life, the human body and how it works.

“As well as increasing their scientific knowledge, this programme will also help to develop creativity, communication and critical-thinking skills. At Almac, we are keen to help children understand that STEAM is for everyone and leads to so many diverse and fulfilling careers right here in Northern Ireland.”

Each of the schools will receive a Science-in-a-Box programme, along with a training webinar, resources and support from staff at Almac and STEAM Education Ltd based in Cork.


About Almac Group

A unique culture delivering exceptional solutions.

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 6,500 highly skilled personnel across 18 facilities including Europe, the US and Asia.

To keep up to date with latest news, follow us on Twitter and LinkedIn or visit almacgroup.com.


Back to news